• OPEN AN ACCOUNT
Indian Indices
Sensex
72,265.31 -373.39
( -0.51%)
Global Indices
Nasdaq
51,194.40 -347.88
(-0.67%)
Dow Jones
7,822.15 -17.78
(-0.23%)
Hang Seng
70,229.08 -454.90
(-0.64%)
Nikkei 225
10,456.95 -84.74
(-0.80%)
Forex
USD-INR
96.37 0.10
(0.10%)
EUR-INR
108.33 0.45
(0.42%)
GBP-INR
127.68 0.44
(0.34%)
JPY-INR
0.61 0.00
(0.01%)

EQUITY - MARKET SCREENER

Glaxosmithkline Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value()
500660
INE159A01016
132.2958859
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLAXO
42.15
44608.84
EPS(TTM)
Face Value()
Div & Yield %
62.48
10
2.16
 

Ducon Infratechnologies consolidated net profit declines 48.75% in the March 2026 quarter
Jun 01,2026
Net profit of Ducon Infratechnologies declined 48.75% to Rs 1.85 crore in the quarter ended March 2026 as against Rs 3.61 crore during the previous quarter ended March 2025. Sales declined 15.50% to Rs 100.24 crore in the quarter ended March 2026 as against Rs 118.63 crore during the previous quarter ended March 2025.

For the full year,net profit declined 18.97% to Rs 10.98 crore in the year ended March 2026 as against Rs 13.55 crore during the previous year ended March 2025. Sales declined 6.93% to Rs 419.40 crore in the year ended March 2026 as against Rs 450.63 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales100.24118.63 -16 419.40450.63 -7
OPM %5.697.50 -6.326.98 -
PBDT3.365.51 -39 17.6920.66 -14
PBT3.024.87 -38 16.3619.38 -16
NP1.853.61 -49 10.9813.55 -19